Ischemia-induced renal expression of hyaluronan and CD44 in diabetic rats

Nephron - Experimental Nephrology

Volumn 103, Issue 3, 2006, Pages

  Melin, Jan ^a,d   Hellberg, Olof ^a   Funa, Keiko ^b   Hällgren, Roger ^a   Larsson, Erik ^a,c   Fellström, Bengt C ^a  

^a UPPSALA UNIVERSITY   (Sweden)

^b UNIVERSITY OF GOTHENBURG   (Sweden)

^c NORWEGIAN UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Norway)

^d UPPSALA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

CD44; Diabetes mellitus, rat; Hyaluronan; Inflammatory cells; Ischemia reperfusion

Indexed keywords

HERMES ANTIGEN; HYALURONIC ACID; STREPTOZOCIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; IMMUNOHISTOCHEMISTRY; INFLAMMATORY CELL; KIDNEY CORTEX; KIDNEY INJURY; KIDNEY ISCHEMIA; KIDNEY MEDULLA; KIDNEY TUBULE CELL; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; RENAL ARTERY; STREPTOZOCIN DIABETES; WATER CONTENT;

ANIMALS; ANTIGENS, CD44; BODY WATER; DIABETES MELLITUS, EXPERIMENTAL; DIABETIC NEPHROPATHIES; HYALURONIC ACID; INFLAMMATION; ISCHEMIA; KIDNEY; MALE; RATS; RATS, WISTAR; TISSUE DISTRIBUTION;

EID: 33745435748     PISSN: 16602129     EISSN: None     Source Type: Journal    
DOI: 10.1159/000092193     Document Type: Article

References (42)

1. Maisonneuve P, Agodoa L, Gellert R, Stewart JH, Buccianti G, Lowenfels AB, Wolfe RA, Jones E, Disney AP, Briggs D, McCredie M, Boyle P: Distribution of primary renal diseases leading to end-stage renal failure in the United States, Europe, and Australia/New Zealand: results from an international comparative study. Am J Kidney Dis 2000;35:157-165.
2. Bohle A, Wehrmann M, Bogenschutz O, Batz C, Müller CA, Müller GA: The pathogenesis of chronic renal failure in diabetic nephropathy: investigation of 488 cases of diabetic glomerulosclerosis. Pathol Res Pract 1991;187:251-259.
3. Kuramochi G, Homma S: Postischemic recovery process of renal oxygen consumption in normal and streptozotocin diabetic rats. Ren Fail 1993;15:587-594.
4. Kuramochi G, Homma S: Effects of furosemide on renal oxygen consumption after ischemia in normal and streptozotocin diabetic rats. Nephron 1993;64:436-442.
5. Wald H, Markowitz H, Zevin S, Popovtzer MM: Opposite effects of diabetes on nephrotoxic and ischemic acute tubular necrosis. Proc Soc Exp Biol Med 1990;195:51-56.
6. Melin J, Hellberg O, Aküyrek M, Källskog Ö, Larsson E, Fellström B: Ischemia causes rapidly progressive nephropathy in the diabetic rat. Kidney Int 1997;52:985-991.
7. Goor Y, Peer G, Iaina A, Blum M, Wollman Y, Chernikovsky T, Silverberg D, Cabili S: Nitric oxide in ischaemic acute renal failure of streptozotocin diabetic rats. Diabetologia 1996;39:1036-1040.
8. Melin J, Hellberg O, Larsson E, Zezina L, Fellstrom BC: Protective effect of insulin on ischemic renal injury in diabetes mellitus. Kidney Int 2002;61:1383-1392.
9. Laurent TC, Fraser JR: Hyaluronan. FASEB J 1992;6:2397-2404.
10. Hällgren R, Gerdin B, Tufveson G: Hyaluronic acid accumulation and redistribution in rejecting rat kidney graft: relationship to the transplantation edema. J Exp Med 1990;171:2063-2076.
11. Farber SJ, Praag DV: Composition of glycosaminoglycans (mucopolysaccharides) in rabbit renal papillae. Biochim Biophys Acta 1970;208:219-226.
12. Berenson GS, Ruiz H, Dalferes ER Jr, Dugan FA, Radhakrishnamurthy B: Acid mucopolysaccharide changes in diabetic kidneys. Diabetes 1970;19:161-170.
13. Lewington AJ, Padanilam BJ, Martin DR, Hammerman MR: Expression of CD44 in kidney after acute ischemic injury in rats. Am J Physiol 2000;278:R247-R254.
14. Johnsson C, Tufveson G, Wahlberg J, Hällgren R: Experimentally- induced warm renal ischemia induces cortical accumulation of hyaluronan in the kidney. Kidney Int 1996;50:1224-1229.
15. Wells A, Larsson E, Hanas E, Laurent T, Hällgren R, Tufveson G: Increased hyaluronan in acutely rejecting human kidney grafts. Transplantation 1993;55:1346-1349.
16. Jones S, Phillips AO: Regulation of renal proximal tubular epithelial cell hyaluronan generation: implications for diabetic nephropathy. Kidney Int 2001;59:1739-1749.
17. Wüthrich RP: The proinflammatory role of hyaluronan-CD44 interactions in renal injury (editorial). Nephrol Dial Transplant 1999;14:2554-2556.
18. Essawy M, Soylemezoglu O, Muchaneta KE, Shortland J, Brown CB, el NA: Myofibroblasts and the progression of diabetic nephropathy. Nephrol Dial Transplant 1997;12:43-50.
19. Forbes JM, Hewitson TD, Becker GJ, Jones CL: Ischemic acute renal failure: long-term histology of cell and matrix changes in the rat. Kidney Int 2000;57:2375-2385.
20. Muchaneta-Kubara EC, El Nahas AM: Myofibroblast phenotypes expression in experimental renal scarring. Nephrol Dial Transplant 1997;12:904-915.
21. Johnson RJ, Alpers CE, Yoshimura A, Lombardi D, Pritzl P, Floege J, Schwartz SM: Renal injury from angiotensin II-mediated hypertension. Hypertension 1992;19:464-474.
22. Gerdin B, Hällgren R: Dynamic role of hyaluronan (HYA) in connective tissue activation and inflammation. J Intern Med 1997;242:49-55.
23. Heldin P, Laurent TC, Heldin CH: Effect of growth factors on hyaluronan synthesis in cultured human fibroblasts. Biochem J 1989;258:919-922.
24. Waldenström A, Martinussen HJ, Gerdin B, Hällgren R: Accumulation of hyaluronan and tissue edema in experimental myocardial infarction. J Clin Invest 1991;88:1622-1628.
25. Wolff SP: Diabetes mellitus and free radicals: free radicals, transition metals and oxidative stress in the aetiology of diabetes mellitus and complications. Br Med Bull 1993;49:642-652.
26. Mezzetti A, Cipollone F, Cuccurullo F: Oxidative stress and cardiovascular complications in diabetes: isoprostanes as new markers on an old paradigm. Cardiovasc Res 2000;47:475-488.
27. Baud L, Ardaillou R: Involvement of reactive oxygen species in kidney damage. Br Med Bull 1993;49:621-629.
28. Jun Z, Hill PA, Lan HY, Foti R, Mu W, Atkins RC, Nikolic PD: CD44 and hyaluronan expression in the development of experimental crescentic glomerulonephritis. Clin Exp Immunol 1997;108:69-77.
29. Lesley J, Schulte R, Hyman R: Binding of hyaluronic acid to lymphoid cell lines is inhibited by monoclonal antibodies against Pgp-1. Exp Cell Res 1990;187:224-233.
30. Oertli B, Fan X, Wuthrich RP: Characterization of CD44-mediated hyaluronan binding by renal tubular epithelial cells. Nephrol Dial Transplant 1998;13:271-278.
31. DeGrendele HC, Kosfiszer M, Estess P, Siegelman MH: CD44 activation and associated primary adhesion is inducible via T cell receptor stimulation. J Immunol 1997;159:2549-2553.
32. Rouschop KM, Sewnath ME, Claessen N, Roelofs JJ, Hoedemaeker I, van der Neut R, Aten J, Pals ST, Weening JJ, Florquin S: CD44 deficiency increases tubular damage but reduces renal fibrosis in obstructive nephropathy. J Am Soc Nephrol 2004;15:674-686.
33. Benz PS, Fan X, Wuthrich RP: Enhanced tubular epithelial CD44 expression in MRL-lpr lupus nephritis. Kidney Int 1996;50:156-163.
34. Sibalic V, Fan X, Loffing J, Wüthrich RP: Up-regulated renal tubular CD44, hyaluronan, and osteopontin in kdkd mice with interstitial nephritis. Nephrol Dial Transplant 1997;12:1344-1353.
35. Wu JC, Fan GM, Kitazawa K, Sugisaki T: The relationship of adhesion molecules and leukocyte infiltration in chronic tubulointerstitial nephritis induced by puromycin aminonucleoside in Wistar rats. Clin Immunol Immunopathol 1996;79:229-235.
36. McNeil JD, Wiebkin OW, Betts WH, Cleland LG: Depolymerisation products of hyaluronic acid after exposure to oxygen-derived free radicals. Ann Rheum Dis 1985;44:780-789.
37. Oertli B, Beck SB, Fan X, Wüthrich RP: Mechanisms of hyaluronan-induced up-regulation of ICAM-1 and VCAM-1 expression by murine kidney tubular epithelial cells: hyaluronan triggers cell adhesion molecule expression through a mechanism involving activation of nuclear factor-kappa B and activating protein-1. J Immunol 1998;161:3431-3437.
38. McKee CM, Penno MB, Cowman M, Burdick MD, Strieter RM, Bao C, Noble PW: Hyaluronan (HA) fragments induce chemokine gene expression in alveolar macrophages. The role of HA size and CD44. J Clin Invest 1996;98:2403-2413.
39. Beck SB, Oertli B, Pasch T, Wüthrich RP: Hyaluronan induces monocyte chemoattractant protein-1 expression in renal tubular epithelial cells. J Am Soc Nephrol 1998;9:2283-2290.
40. Laurent TC: Biochemistry of hyaluronan. Acta Otolaryngol Suppl 1987;442:7-24.
41. Johnsson C, Hällgren R, Elvin A, Gerdin B, Tufveson G: Hyaluronidase ameliorates rejection-induced edema. Transplant Int 1999;12:235-243.
42. Johnsson C, Tufveson G, Hällgren R: Monitoring of intragraft pressure of rejecting organs: increased tissue pressure can be reduced by hyaluronidase therapy. Transplantation 2000;70:1575-1580.